• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number PRD-06419
Device Problem Erratic Results (4059)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/02/2023
Event Type  malfunction  
Manufacturer Narrative
Hologic technical support (ts) advised customer to perform a full monthly maintenance and clean the sample and reagent preparation areas.Ts reviewed logs and found no evidence of contamination based on the rlus and kinetic profiles of the results.There were no hardware failures which could have contributed to questionable results.Customer understood and agreed with the log review.Ts advised customer to recollect patient samples in the future if they are uncertain of the validity of the results.Customer performed monthly maintenance and monitored for further issues, but instrument was operational.No further issues were reported.As part of eua agreement, fda requires all aptima sars-cov-2 assay questioning results and false results (confirmed or not) complaints to be reported as malfunction mdr.
 
Event Description
Customer reported they suspected contamination in one sars-cov-2 tma run using assay lot: 329277 on panther plus instrument sn: (b)(4).The worklist in question, (b)(4), had (b)(4) positives out of (b)(4) samples, as well as (b)(4) low positive samples (b)(6).The samples were not retested, but customer requested a log review from hologic technical support to confirm if the sample results were valid.The information provided by the customer was insufficient to characterize any sample as a confirmed false result.Results were not reported to patients.There were no associated/reported adverse events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA SARS COV-2
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
kyleigh jacobs
10210 genetic center drive
san diego, CA 92121
8584108566
MDR Report Key16117386
MDR Text Key308644134
Report Number2024800-2023-00003
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPRD-06419
Device Lot Number329277
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/02/2023
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-